QuickVue COVID-19 Test
FDA 510(k) K231795 · Quidel Corporation
510(k) numberK231795
Submission
- Device name
- QuickVue COVID-19 Test
- Applicant
- Quidel Corporation
San Diego, CA, US - Received
- June 20, 2023
- Decision date
- March 22, 2024
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- QYT – Over-The-Counter Covid-19 Antigen Test
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3984
- Specialty
- Microbiology
For the rapid, qualitative detection of SARS-CoV-2 virus nucleocapsid protein antigen in individuals 2 years and older.
Other 510(k)s with product code QYT
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K260754 | Fastep COVID-19 Antigen Pen Home Test; Fastep COVID-19 Antigen Pen TestQYT · Traditional | Assure Tech., LLC | 06/05/2026SE |
| K260095 | Heal-Check Rapid COVID-19 Antigen Self-TestQYT · Traditional | Healgen Scientific,, LLC | 04/13/2026SE |
| K251916 | GenBody COVID-19 Ag Home TestQYT · Traditional | Genbody.Inc. | 03/13/2026SE |
| K251595 | COVID-19 Detect Rapid Self -TestQYT · Traditional | InBios International, Inc. | 10/12/2025SE |
| K251753 | GenaCheck COVID-19 Rapid Self-TestQYT · Traditional | Genabio Diagnostics, Inc. | 09/05/2025SE |
| K241313 | OHC COVID-19 Antigen Self TestQYT · Traditional | Osang, LLC | 05/30/2025SE |
| K243518 | BinaxNOW COVID-19 Antigen Self TestQYT · Traditional | Abbott Diagnostics Scarborough, Inc. | 02/11/2025SE |
| K241915 | CareSuperb COVID-19 Antigen Home TestQYT · Traditional | Access Bio, Inc. | 01/29/2025SE |
| K241317 | Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)QYT · Traditional | Guangzhou Wondfo Biotech Co., Ltd. | 09/30/2024SE |
| K240728 | CorDx Tyfast COVID-19 Ag Rapid Test; CorDx COVID-19 Ag TestQYT · Traditional | CorDx, Inc. | 06/21/2024SE |
More from CorDx, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K232286 | Savanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna InstrumentPGI · Traditional | 12/20/2023SE |
| K233688 | Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab SetQVF · Special | 12/13/2023SE |
| K230349 | Lyra RSV+hMPV AssayOEM · Special | 03/10/2023SE |
| K230236 | Lyra Influenza A+B AssayOZE · Special | 03/03/2023SE |
| K211342 | Sofia 2 Campylobacter FIALQP · Traditional | 11/23/2021SE |
| K173496 | Sofia 2 Lyme FIA, Sofia Lyme Control SetLSR · Dual Track | 08/30/2018SE |
| K181029 | Solana Bordetella Complete AssayOZZ · Traditional | 07/15/2018SE |
| K173691 | Sofia Lyme FIA, Sofia 2 analyzer, Sofia 2 Installation PackLSR · Traditional | 02/28/2018SE |
| K180288 | QuickVue Influenza A+BPSZ · Special | 02/13/2018SE |
| K173250 | Solana GBS AssayNJR · Traditional | 12/21/2017SE |
Questions and answers
When was QuickVue COVID-19 Test cleared by the FDA?
QuickVue COVID-19 Test (K231795) received a 510(k) decision of Substantially Equivalent on March 22, 2024, 276 days after the submission was received.
What is the product code of K231795?
The FDA product code is QYT – Over-The-Counter Covid-19 Antigen Test, a Class II (moderate risk) device regulated under 21 CFR 866.3984.